Clinical Trial: Real-World Study of BCL-2 Inhibitor-Based Regimens in Chronic Lymphocytic Leukemia

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07874451) titled 'Real-World Study of BCL-2 Inhibitor-Based Regimens in Chronic Lymphocytic Leukemia' on Oct. 08.

Brief Summary: This non-interventional, real-world cohort study aims to evaluate treatment patterns, clinical outcomes, and safety of BCL-2 inhibitor-based regimens in patients with CLL treated in routine clinical practice. Data collected from participating centers will be used to characterize patient demographics, disease characteristics, treatment exposure, effectiveness outcomes, and adverse events, thereby providing real-world evidence to support clinical decision-making and optimize patient management.

Study Start Date: Oct., 2026 ...